68
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J)

, , , , , , , , , , , , & show all
Pages 447-454 | Received 11 Mar 2008, Accepted 21 Mar 2008, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (16)

Yasuharu Nakashima, Masakazu Kondo, Eisuke Shono, Takashi Ishinishi, Hiroshi Tsukamoto, Koji Kuroda, Akira Maeyama, Hiroshi Harada, Masayuki Maekawa, Takashi Shimauchi, Ryuji Nagamine, Hiroshi Jojima, Seiji Yoshizawa, Tomomi Tsuru, Takeshi Otsuka, Hisaaki Miyahara, Eiichi Suematsu, Ken Wada, Shigeru Yoshizawa, Yasushi Inoue, Takaaki Fukuda, Satoshi Ikemura & Akihisa Haraguchi. (2020) Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice. Modern Rheumatology 30:5, pages 807-815.
Read now
Kosaku Murakami, Masahiro Sekiguchi, Shintaro Hirata, Takao Fujii, Kiyoshi Matsui, Satoshi Morita, Koichiro Ohmura, Yutaka Kawahito, Norihiro Nishimoto, Tsuneyo Mimori & Hajime Sano. (2019) Predictive factors for structural remission using abatacept: Results from the ABROAD study. Modern Rheumatology 29:3, pages 406-412.
Read now
Masao Nawata, Kazuyoshi Saito, Shunsuke Fukuyo, Shintaro Hirata & Yoshiya Tanaka. (2016) Clinically relevant radiographic progression in joint destruction in RA patients with abnormal MMP-3 or high levels of CRP despite 1-year treatment with infliximab. Modern Rheumatology 26:6, pages 807-812.
Read now
Takeshi Mochizuki, Koichiro Yano, Katsunori Ikari, Ryo Hiroshima, Hiromitsu Takaoka, Kosei Kawakami, Naoko Koenuma, Toshikatsu Shirahata & Shigeki Momohara. (2016) The efficacy of abatacept in Japanese patients with rheumatoid arthritis: 104 weeks radiographic and clinical results in clinical practice. Modern Rheumatology 26:4, pages 499-506.
Read now
Yoshiya Tanaka, Satoshi Kubo, Hisashi Yamanaka, Koichi Amano, Shintaro Hirata, Eiichi Tanaka, Hayato Nagasawa, Hidekata Yasuoka & Tsutomu Takeuchi. (2014) Efficacy and safety of abatacept in routine care of patients with rheumatoid arthritis: Orencia® as Biological Intensive Treatment for RA (ORBIT) study. Modern Rheumatology 24:5, pages 754-762.
Read now
Shunsuke Fukuyo, Kazuyoshi Saito, Kunihiro Yamaoka, Norifumi Sawamukai, Shintaro Hirata, Masao Nawata, Shigeru Iwata & Yoshiya Tanaka. (2014) Efficacy and safety of reducing duration of infliximab infusion. Modern Rheumatology 24:2, pages 275-280.
Read now
Ayako Kubota, Takashi Nakamura, Yoshiyasu Miyazaki, Masayuki Sekiguchi & Toru Suguro. (2012) Perioperative complications in elective surgery in patients with rheumatoid arthritis treated with biologics. Modern Rheumatology 22:6, pages 844-848.
Read now
Tsutomu Takeuchi, Yoshiya Tanaka, Yuko Kaneko, Eiichi Tanaka, Shintaro Hirata, Takahiko Kurasawa, Satoshi Kubo, Kazuyoshi Saito, Kumi Shidara, Noriko Kimura, Hayato Nagasawa, Hideto Kameda, Koichi Amano & Hisashi Yamanaka. (2012) Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study). Modern Rheumatology 22:3, pages 327-338.
Read now
Yoshiya Tanaka, Hisashi Yamanaka, Kazuyoshi Saito, Shigeru Iwata, Ippei Miyagawa, Yohei Seto, Shigeki Momohara, Hayato Nagasawa, Hideto Kameda, Yuko Kaneko, Keisuke Izumi, Koichi Amano & Tsutomu Takeuchi. (2012) Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept. Modern Rheumatology 22:2, pages 186-194.
Read now
Hiroki Wakabayashi, Masahiro Hasegawa, Yosuke Nishioka, Akihiro Sudo & Kusuki Nishioka. (2012) Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etanercept after previous infliximab failure? A retrospective study. Modern Rheumatology 22:1, pages 116-121.
Read now
Masahiro Tada, Takeshi Nakanishi, Chika Hirata, Tadashi Okano, Yuko Sugioka, Shigeyuki Wakitani, Hiroaki Nakamura & Tatsuya Koike. (2010) Use of infliximab in a patient with pyoderma gangrenosum and rheumatoid arthritis. Modern Rheumatology 20:6, pages 598-601.
Read now
Hideto Kameda, Yukitaka Ueki, Kazuyoshi Saito, Shouhei Nagaoka, Toshihiko Hidaka, Tatsuya Atsumi, Michishi Tsukano, Tsuyoshi Kasama, Shunichi Shiozawa, Yoshiya Tanaka & Tsutomu Takeuchi. (2010) Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial. Modern Rheumatology 20:6, pages 531-538.
Read now
Masanobu Horikoshi, Takeshi Suzuki, Makoto Sugihara, Yuya Kondo, Hiroto Tsuboi, Takeaki Uehara, Maasa Hama, Kaoru Takase, Shigeru Ohno, Yoshiaki Ishigatsubo, Yuri Yoshida, Akira Sagawa, Kei Ikeda, Toshiyuki Ota, Isao Matsumoto, Satoshi Ito & Takayuki Sumida. (2010) Comparison of low-field dedicated extremity magnetic resonance imaging with articular ultrasonography in patients with rheumatoid arthritis. Modern Rheumatology 20:6, pages 556-560.
Read now
Tsutomu Takeuchi, Nobuyuki Miyasaka, Kazuhiko Inoue, Tohru Abe & Takao Koike. (2009) Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study. Modern Rheumatology 19:5, pages 478-487.
Read now
Hayato Nagasawa, Hideto Kameda, Naoya Sekiguchi, Kouichi Amano & Tsutomu Takeuchi. (2009) Improvement of the HAQ score by infliximab treatment in patients with RA: its association with disease activity and joint destruction. Modern Rheumatology 19:2, pages 166-172.
Read now

Articles from other publishers (12)

Mochihito Suzuki, Shuji Asai, Ryota Hara, Yuji Hirano, Satomi Nagamine, Tetsuya Kaneko, Hideo Sakane, Tadashi Okano, Yutaka Yoshioka, Shigeyoshi Tsuji, Hiroki Wakabayashi, Yuya Takakubo, Toki Takemoto, Takayoshi Fujibayashi, Tatsuo Watanabe, Takefumi Kato, Hajime Ishikawa, Yoshihisa Nasu, Eiji Torikai, Atsushi Kaneko, Hideki Takagi, Toshifumi Fujiwara, Daisuke Kihira, Kyosuke Hattori, Kenji Kishimoto, Yoshifumi Ohashi, Yasumori Sobue, Yutaka Yokota, Tsuyoshi Nishiume, Kenya Terabe, Nobunori Takahashi, Masayo Kojima, Shiro Imagama & Toshihisa Kojima. (2023) Choice of and response to treatment in patients with early-diagnosed rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J). Journal of Orthopaedic Science.
Crossref
Takanori Akai, Daigo Taniguchi, Ryo Oda, Maki Asada, Shogo Toyama, Daisaku Tokunaga, Takahiro Seno, Yutaka Kawahito, Yosuke Fujii, Hirotoshi Ito, Hiroyoshi Fujiwara & Toshikazu Kubo. (2016) Prediction of radiographic progression in synovitis-positive joints on maximum intensity projection of magnetic resonance imaging in rheumatoid arthritis. Clinical Rheumatology 35:4, pages 873-878.
Crossref
Ahmad H. Alghadir, Sami A. Gabr & Einas S. Al-Eisa. (2016) Green tea and exercise interventions as nondrug remedies in geriatric patients with rheumatoid arthritis. Journal of Physical Therapy Science 28:10, pages 2820-2829.
Crossref
Koshiro SONOMOTO, Kunihiro YAMAOKA & Yoshiya TANAKA. (2014) An Approach to Bone and Cartilage Repair of Rheumatoid Arthritis by Mesenchymal Stem Cells間葉系幹細胞による関節リウマチの骨軟骨再生へのアプローチ. Journal of UOEH 36:2, pages 141-146.
Crossref
Masataka Nishikawa, Hajime Owaki, Koichiro Takahi & Takeshi Fuji. (2014) Disease Activity, Knee Function, and Walking Ability in Patients with Rheumatoid Arthritis 10 Years after Primary Total Knee Arthroplasty. Journal of Orthopaedic Surgery 22:1, pages 84-87.
Crossref
Yasuo Niki, Tsutomu Takeuchi, Masanori Nakayama, Hayato Nagasawa, Takahiko Kurasawa, Harumoto Yamada, Yoshiaki Toyama & Takeshi Miyamoto. (2012) Clinical Significance of Cartilage Biomarkers for Monitoring Structural Joint Damage in Rheumatoid Arthritis Patients Treated with Anti-TNF Therapy. PLoS ONE 7:5, pages e37447.
Crossref
Yoshiya Tanaka. (2012) Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis. Current Opinion in Rheumatology 24:3, pages 319-326.
Crossref
Tsutomu Takeuchi & Hideto Kameda. (2010) The Japanese experience with biologic therapies for rheumatoid arthritis. Nature Reviews Rheumatology 6:11, pages 644-652.
Crossref
Yoshiya Tanaka. (2010) Achieving drug-free remission: elucidating the role of TNF in rheumatoid arthritisinhibitors. International Journal of Clinical Rheumatology 5:4, pages 391-393.
Crossref
Hayato Nagasawa, Hideto Kameda, Naoya Sekiguchi, Koichi Amano & Tsutomu Takeuchi. (2010) Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis. Modern Rheumatology 20:4, pages 337-342.
Crossref
Tsutomu Takeuchi, Nobuyuki Miyasaka, Kazuhiko Inoue, Tohru Abe & Takao Koike. (2009) Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study. Modern Rheumatology 19:5, pages 478-487.
Crossref
Hayato Nagasawa, Hideto Kameda, Naoya Sekiguchi, Kouichi Amano & Tsutomu Takeuchi. (2008) Improvement of the HAQ score by infliximab treatment in patients with RA: its association with disease activity and joint destruction. Modern Rheumatology 19:2, pages 166-172.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.